Kringle Pharma, Inc.
Notice of Exercise Completion of the 16th Stock Acquisition Rights Issued Through Third-Party Allotment (Exercise Price Adjustment Provisions) and Monthly Exercise Status
announces the completion of the exercise of the 16th stock acquisition rights. For the monthly exercise status, 2,100 rights were exercised against 210,000 shares issued, representing 12.4% of total issued rights. Total issued shares: 8,383,200; unexercised rights: 0. As of August 27.
Key Figures
- Allocated shares: 210,000 shares
- Total issuing stock acquisition rights: 17,000 rights
- Number of exercised stock acquisition rights: 2,100 rights
AI要約
Overview
Today, we announce the completion of all exercises of the 16th stock acquisition rights issued through third-party allotment with exercise price adjustment provisions. In the monthly exercise status, 2,100 rights were exercised against 210,000 allocated shares, with an exercise rate of 12.4% of the total issued rights. Unexercised shares stand at 0, and the total exercise ratio records 3.1%.
Impact going forward
Total issued shares are 8,383,200 (including 183 treasury shares). The completion of this exercise is expected to have a limited dilutive impact. All monthly exercise status for August 2026 has been completed, and we will continue to disclose stock option management status.
Klinglea Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
